Recent Security Class Actions

ADMA Biologics Inc Common Stock (NASDAQ: ADMA)

10 Days left to seek lead plaintiff status.

Company Name:ADMA Biologics Inc Common Stock
Stock Symbol:NASDAQ: ADMA
Class Period Start:08/09/2024
Class Period End (inclusive):03/25/2026
Filing Deadline:08/10/2026

The Complaint alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; and (4) as a result, defendants’ statements about ADMA Biologics’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

ADMA Biologics Inc Common Stock (NASDAQ: ADMA) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address